The makers of weight-loss medications like Ozempic and Wegovy are being sued by patients claiming these companies failed to warn patients about the risks of taking their drugs. A Philadelphia federal court will soon evaluate claims against Novo Nordisk and Eli Lilly. The lawsuit consolidates multiple claims from several patients who experienced gastrointestinal issues after taking the popular drugs. Recent studies have shown that these GLP-1 drugs are associated with higher risks of gastroparesis, intestinal blockages, and pancreatitis. (Study Finds)
Makers Of Weight-loss Drugs Being Sued
Jun 24, 2024 | 8:00 PM